Transgenic models of autoimmune disease

Clinical and Experimental Immunology

Volumn 127, Issue 1, 2002, Pages 4-11

  Boyton, R J ^a   Altmann, D M ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity; HLA; Transgenic mouse

Indexed keywords

ANTIGEN; EPITOPE;

ALLELE; ANIMAL MODEL; AUTOIMMUNE DISEASE; CELL CLONE; CELL SPECIFICITY; DISEASE MODEL; EXPERIMENTAL MODEL; GENE DELETION; GENE MAPPING; HLA SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; REVIEW; T LYMPHOCYTE; THYMUS; TRANSGENIC ANIMAL; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HISTOCOMPATIBILITY ANTIGENS; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0036174833     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01771.x     Document Type: Review

References (61)

1. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice
2. Colitis in transgenic and knockout models of human inflammatory bowel disease
3. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease
4. Isolation of myelin basic protein-reactive T-cell lines from normal human blood
5. + thymocytes
6. Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens
7. Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion
8. T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance
9. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice
10. Transgenic mice that express a myelin basic protein specific T cell receptor develop spontaneous autoimmunity
11. Low avidity recognition of self antigen by T cells permits escape from self tolerance
12. Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein
13. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
14. Different modes of pathogenesis in T-cell-dependent autoimmunity: Clues from two TCR transgenic systems
15. + T cells expressing endogenous T cell receptor chains protect myelin basic protein specific transgenic mice from spontaneous autoimmune encephalomyelitis
16. Checkpoints in the progression of autoimmune disease: Lessons from diabetes models
17. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor
18. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor
19. Determinants of the B-cell response against a transgenic autoantigen
20. A role of Hsp60 in autoimmune diabetes: Analysis in a transgenic model
21. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice
22. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease
23. Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells
24. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells
25. Invited anniversary review: HLA associated diseases
26. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex
27. HLA transgenic mice for the analysis of autoimmune disease
28. Human autoimmunity genes in mice
29. Strong xenogeneic HLA response in transgenic mice after introducing an alpha 3 domain into HLA B27
30. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein
31. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
32. HLA-restricted recognition of viral antigens in HLA transgenic mice
33. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice
34. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1
35. Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum
36. Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice
37. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice
38. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4
39. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice
40. Transgenic mice expressing human HLA and CD8 molecules generate HLA-restricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection
41. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR (alpha1*0101,beta1*0401) transgenic mice
42. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice
43. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin
44. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401
45. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles
46. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif
47. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: Analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice
48. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA (null) NOD mice
49. HLA-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice
50. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA) -DQ molecules to the development of diabetes
51. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: An animal model of HLA-B27-associated human disorders
52. Inflammatory disease in HLA-B27 transgenic rats
53. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats
54. Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen
55. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen
56. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen
57. Transgenic mouse models of rheumatoid arthritis
58. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4 (+) T cells from human DQ transgenic mice
59. T cell recognition of human preproinsulin peptides depends on the polymorphism at HLA DQ locus: A study using HLA DQ8 and DQ6 transgenic mice
60. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis
61. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA) -DR2-MBP 85-99 complex